
Tanvee Varma, MD
@tanveevarma
PGY-2 @BrighamMedRes ⚕• @Yalemed @FulbrightPrgrm @Wellesley '18 alum • clinical trial diversity, drug policy, & equity in cancer care • she/her • 🪴🤿📚
ID: 1258574028241076228
08-05-2020 01:46:51
260 Tweet
423 Followers
365 Following


The Unnati Mehta fan club became the Dr. Unnati Mehta fan club today. Big day for us, bigger day for our exposome queen. We love you so much. So proud of you 🥹🥹🥹


I've a new short essay at JAMA Network on the doctor unionization movement and how it can counter the capitalist, anti-public-health indoctrination that permeates US medical training and kills our patients. A final point I didn't have space to explain:🧵 jamanetwork.com/journals/jaman…

Thx Jyoti Madhusoodanan (& The Atlantic) for highlighting the impact of under-representing older people in #cancer clinical trials. In many instances, clinicians & pts are forced to make choices in an "evidence-free zone". We must design studies so they apply to actual pts. Yale Cancer Center


Wish I could be there to support Sachit Singal, MD at his 2 moderated presentations at AHA this year! Proud of all his effort to make these projects come to life ♥️ #AHA23

Don't miss Sachit Singal, MD 's presentation on CAD Polygenic Risk Score and Incident Complex Coronary Revascularization in Adults With Atherosclerosis, in 24 hrs in Sci & Tech Hall Zone 2 @giorgiomelloni Robert Giugliano Nicholas Marston Brian Bergmark #AHA23

In a nested prospective study of modes of in-hospital deaths in pts w/cardiogenic shock, heterogeneity in pts w/preceding cardiac arrest may have important implications for future clinical trial design Sachit Singal, MD David Berg @ebohula Critical Care Cardiology Trials Network #AHA23


Among patients with established ASCVD, a CAD polygenic risk score was associated with incident complex coronary revascularization procedures. Sachit Singal, MD Brian Bergmark Nicholas Marston #AHA23


A pleasure to be among such incredible talent driving the field forward at #AHA23, and an honor to present original investigative work from TIMI Study Group and Critical Care Cardiology Trials Network Special shout-out to my incredible mentors for their support and guidance!



🚨 New in Journal of Cardiac Failure — using data from Critical Care Cardiology Trials Network, we describe differences in modes of death in patients with cardiogenic shock. onlinejcf.com/article/S1071-… Thank you to David Berg, Erin Bohula, Dr. David Morrow, and others in TIMI Study Group for your mentorship and support!

🎆NEW: Treating #cancer in last 14d of life can be harmful & wasteful. Some argue that pts at *oncology practices* w/high EOL treatment rates may have better outcomes. NOT TRUE! We found pts at ⬆️ "aggressive" practices did not have ⬆️ survival. JAMA Oncology jamanetwork.com/journals/jamao…

Leaving the Global Genes #RAREHealthEquity Forum this weekend incredibly inspired and my heart full— honored to have been able to speak on a panel about clinical trial diversity 🗣️


Excited to share our work now in JAMA about clinical trial diversity💡📝 Congress gave the FDA the authority to require diversity action plans for clinical trials. Why does this matter? Read more at: ja.ma/4dfK5pO Barbara Bierer Andrew Hantel Dana-Farber


To my family, wife (Tanvee Varma, MD), and friends—thank you for your belief in me To my dad specifically (my cardiology idol)—I inch a little more forward today as I continue to chase your footsteps I am elated to join MGH Cardiology Fellows as a cardiology fellow very soon! 🫀🩺



Awesome M&M conference today on non-occlusive vs occlusive mesenteric #ischemia presented by Tanvee Varma, MD with expert discussants Dr. Brian Bustos, Thiago Oliveira MD, MPH, and Umberto Campia. Humbling and important learning points to remember!
